Patents Assigned to Neurent Medical Limited
  • Patent number: 11896818
    Abstract: The invention provides a device for treating at least one of rhinitis, congestion, and/or rhinorrhea to thereby reduce or eliminate symptoms associated therewith, including, but not limited to, coughing, sneezing, nasal or throat irritation and itching, and difficulty sleeping. The device includes an elongate body, a retractable and expandable multi-segment end effector, and handle, that, as a whole, provide a high level of precise control and feedback to an operator during a procedure. The elongate body includes an electrode array provided along a length thereof configured to deliver energy to specific target sites within the nasal passage and nasal cavity in conjunction with neuromodulation provided by the multi-segment end effector.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: February 13, 2024
    Assignee: Neurent Medical Limited
    Inventor: David Townley
  • Patent number: 11883091
    Abstract: The invention generally relates to systems and methods for improving sleep by treating at least one of rhinitis, congestion, and/or rhinorrhea to thereby reduce or eliminate symptoms associated therewith, including, but not limited to, nasal congestion, coughing, sneezing, and nasal or throat irritation and itching.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: January 30, 2024
    Assignee: Neurent Medical Limited
    Inventor: David Townley
  • Patent number: 11701167
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: July 18, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11684414
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 27, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11666378
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 6, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11576719
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: February 14, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11547473
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 10, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11547472
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: January 10, 2023
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 11419671
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: August 23, 2022
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Patent number: 10695557
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: June 30, 2020
    Assignee: Neurent Medical Limited
    Inventors: David Townley, Brian Shields
  • Publication number: 20200179683
    Abstract: The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.
    Type: Application
    Filed: December 3, 2019
    Publication date: June 11, 2020
    Applicants: Neurent Medical Limited, Neurent Medical Limited
    Inventors: David Townley, Brian Shields